BIOMIND LABS INC. (3XI) — Cash Flow-to-Debt Ratio
BIOMIND LABS INC. (3XI) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of €-38.70K could theoretically repay 0% of its total liabilities (€1.62 Million) in one year. See financial agility of BIOMIND LABS INC. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BIOMIND LABS INC. Cash Flow-to-Debt Ratio (2021–2024)
Historical debt coverage capacity for BIOMIND LABS INC. across 4 annual periods. For the full cash flow conversion analysis, see BIOMIND LABS INC. (3XI) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for BIOMIND LABS INC. (2021–2024)
Year-by-year debt coverage analysis for BIOMIND LABS INC.. Check BIOMIND LABS INC. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.26x | €-354.43K | €1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | €-765.93K | €1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | €-2.15 Million | €336.72K | ▼ -0.8% |
| 2021 | -6.34x | €-2.12 Million | €334.95K | — |